ASML Holding NV: A Long-Term Business Owner's Perspective

Hunting ten-year five-baggers among great growth stocks — pressing the upside question: "Can it get much bigger?"

• QHow large is its market ceiling? Is it expanding an existing pie, or creating an entirely new market?6/10

  A

  Conclusion: ASML is mainly “expanding an existing pie, whose upper bound it largely defines itself,” namely advanced semiconductor lithography. It is not creating a brand-new market from scratch. The ceiling is high, but it depends on how long downstream wafer-fab capex can keep rising, not on ASML opening up new demand by itself. This makes its growth “follow-on and highly certain,” rather than the kind of explosive demand creation that Baillie Gifford most prefers.

  The nature of the pie: an absolute monopolist inside an existing market. Lithography has been an inherent process in chip manufacturing for decades. ASML did not invent the need for lithography; it pushed this existing process to a level of precision others cannot achieve. In EUV, which determines the upper limit of advanced logic and memory process nodes, ASML is currently the only commercial supplier; the report also notes that in DUV it still competes with Canon and Nikon. Its expansion model is therefore to take its share of the existing lithography pie close to 100% and grow with the pie, not to create a category that did not previously exist.

  How high is the ceiling: frame it with the company’s own SAM. In its 2026 Q1 investor materials, ASML reiterated that, under different market and lithography intensity scenarios, its 2030 revenue opportunity is about €44.0 billion to €60.0 billion, with a gross margin opportunity of about 56%–60%. Compared with actual 2025 revenue of €32.67 billion, the company’s own five-year ceiling is roughly “another 35%–84%” of growth. That is substantial, but bounded. The ceiling is set by downstream wafer fabs’ willingness to expand capacity, not by ASML’s ability to raise it unilaterally.

  How much of this is truly “creating a new market”: the incremental growth mainly comes from raising lithography intensity per wafer. ASML’s second growth source is not new customers, but the rising value of lithography equipment embedded in each advanced wafer. High-NA EUV and higher EUV source power lift the ASP of each tool; the report cites Reuters saying a single High-NA tool can reach about $400 million. This is still essentially “thickening the existing pie” through volume and price, not opening a new track like food and beverage. Installed Base Management aftermarket revenue, which reached €8.2 billion in 2025, is the closest thing to “creating a new market,” as a new revenue layer grown on top of the installed base. But it depends on tools already sold, so its scale is naturally constrained by the installed base.

  Honest conclusion: the ceiling is high and the certainty is strong, but this is not an endlessly expanding new continent. It is accurate to view ASML as a company that has defined and monopolized a critical existing pie and is expanding it alongside the AI capex cycle. It is overstated to imagine it is creating the next trillion-euro new market by itself. Its growth ceiling is locked by two things: total global capex for advanced process nodes, and the compression of its serviceable market boundary by geopolitics. In 2025, the share of Chinese customers had already fallen from 36.1% to 29.1%. This is a long, highly visible ski slope, but the top of the slope can be seen.

  Not investment advice. Stock markets involve risk; invest cautiously.

  Jun 10, 2026
• QCan its revenue at least double over the next five years? Will growth be driven mainly by volume, price, or new businesses?4/10

  A

  Conclusion: a revenue doubling within five years, from €32.67 billion in 2025 to about €65.0 billion, is unlikely. It exceeds the upper end of the company’s own ceiling. Growth is real, but it is driven mainly by “price,” meaning higher tool ASP plus a more service-like aftermarket, and by limited “volume.” There is almost no “new business” leg. Treating ASML as a five-year doubling stock forces a Baillie Gifford narrative onto a company whose own guidance says otherwise.

  Start by using the company’s own numbers to disprove “doubling.” Actual 2025 revenue was €32.67 billion; the company’s 2030 revenue opportunity, about five years out, is €44.0 billion–€60.0 billion. Even the optimistic upper end of €60.0 billion is only +84% versus 2025, short of a double; the midpoint of about €52.0 billion is +59%. In other words, even under ASML’s most optimistic official framework, a five-year doubling is merely a ceiling case near the edge, not the base case. The report cites a 2021–2025 revenue CAGR of about 15.1%, which would imply about +101% over five years if linearly extrapolated. But that historical period landed right on the AI and advanced-node supercycle, so treating it as a steady-state guide for the next five years would not be prudent.

  The “volume” leg: constrained by customer capacity-expansion schedules and geopolitics, and therefore bumpy and limited. System shipments are highly cyclical. One comparison is that free cash flow fell back from a high level to €3.25 billion in 2023, according to the report, showing that even when long-term demand rises, annual shipment volumes can fluctuate sharply. Meanwhile, the China market boundary is being compressed: China’s customer share had fallen to 29.1% in 2025. So doubling by “selling many more machines” is not realistic.

  The “price” leg: this is the main driver. Tool ASP keeps rising. A single High-NA EUV tool is about $400 million, according to the report’s Reuters citation, while higher EUV source power and yield raise the lithography value embedded in each advanced wafer. Add the aftermarket: 2025 net service and field option sales, namely Installed Base Management, were €8.19 billion, up 26.2% year over year, faster than 12.4% system-sales growth. This is a high-quality mix of price and sticky aftermarket growth, but its ceiling is locked by the installed base and capacity-expansion cycles.

  The “new business” leg: basically absent. ASML does not have an incubating second category that could contribute tens of billions of euros within five years. Its 2025 investment of about €1.30 billion in Mistral AI, disclosed in the report, is a strategic financial investment, not a new growth business. So “new businesses driving a doubling” has no basis.

  Honest conclusion: “at least doubling in five years” does not hold. A more reasonable expectation is “about 35%–80% growth over five years, led by price (ASP plus services), with volume as a secondary contributor and no new business.” Growth is real, highly certain, and good in quality, but it does not reach Baillie Gifford’s five-year doubling threshold. This item deserves a low score honestly, not a forced fit.

  Not investment advice. Stock markets involve risk; invest cautiously.

  Jun 10, 2026
• QAfter five years, what will take over as the next growth engine? Does this “second curve” exist today?5/10

  A

  Conclusion: ASML’s “second curve” is not a new business. It is two extensions of the same main curve: High-NA EUV, the next equipment generation, and Installed Base Management, monetizing the installed base after sale. Both exist today and already generate revenue, but both depend on the main curve of selling lithography equipment to wafer fabs. They are not new growth poles independent of the core business. Frankly, ASML lacks a Baillie-style second curve that is decoupled from the main business and can independently carry the next decade.

  Candidate one: High-NA EUV. This is a generational upgrade of the main curve, not a new curve. It raises the value per tool; the report cites Reuters saying a single tool is about $400 million. It is the core engine of ASP expansion over the next 5–10 years. But it is still a more expensive version of the same type of equipment, sold to the same group of wafer-fab customers, and the report explicitly notes that commercial success will take time and that some customers are cost-sensitive. It can extend the slope of the main curve, but if the core business, advanced logic and memory capacity expansion, loses momentum, it cannot stand alone. Classification: an extension of the main curve, not a second curve.

  Candidate two: Installed Base Management, the aftermarket. This looks most like a second curve, but it depends on the installed base. This leg is already running in concrete terms: 2025 IBM, namely net service and field option sales, reached €8.19 billion, up 26.2% year over year, and reached €2.5 billion in Q1 2026 alone. It turns the business from one-off equipment sales into a compound model of equipment plus ongoing service, upgrades, and software. Its stability and predictability are far higher than system sales, so this is the part that is truly shifting gears. But its ceiling is determined by the historical installed base. The aftermarket cannot ultimately be larger than the total machines already sold, so it can smooth the curve and improve business quality, but it cannot grow independently of the main business.

  Does the second curve “exist today”: yes, but these are “same-origin extensions,” not “different-origin new engines.” That is exactly the difference between ASML and a typical Baillie Gifford growth stock. The latter, such as a platform company, often has a second category that is orthogonal to the original business and capable of independent explosive growth. ASML’s two candidate curves grow on the same tree, share the same customer base, and depend on the same capex cycle. The report’s optimism about the long runway, with a 2030 revenue opportunity of €44.0 billion–€60.0 billion, is entirely built on “the main curve continues, plus High-NA and services.” It does not rely on any decoupled new business.

  Honest conclusion: the successor is already on the field and already contributes cash, and its quality is high. But these are “range extenders” for the main curve, meaning more expensive equipment plus a sticky aftermarket, not independent second growth poles. If the main curve of AI-driven advanced-node capex slows, High-NA and the aftermarket will both come under pressure at the same time. This is crucial when judging growth durability over the next decade. A good-looking aftermarket should not be mistaken for a fully formed second leg.

  Not investment advice. Stock markets involve risk; invest cautiously.

  Jun 10, 2026
• QWhat is its core competitive advantage? Will this moat widen or narrow over the next three to five years?8/10

  A

  Conclusion: ASML’s core competitive advantage is that it is almost the only supplier of EUV lithography, the step that determines the limits of advanced chip processes, combined with extremely high customer switching costs and a national-scale ecosystem barrier. This is one of the deepest moats in the entire market. Over the next three to five years, the technical dimension, through High-NA, light sources, and aftermarket software, is widening; the customer-relationship dimension is stable; the geopolitical dimension is narrowing. The net judgment is “core stable, technology slightly wider, boundaries compressed by politics,” not a one-way widening.

  The essence of the core advantage is not “doing it better,” but “others can hardly produce an equivalent commercial product.” In EUV, ASML is currently the only commercial supplier; in DUV, the report says its main competitors are only Canon and Nikon. The difficulty of replicating it sits at the industrial-ecosystem level. The report cites Reuters saying EUV took nearly twenty years and billions of euros of R&D from prototype to commercialization. The supply-chain barrier is just as important: the report cites ZEISS SMT saying that about 80% of the world’s chips currently use optical systems it provides together with ASML. This moat cannot be defended by a single patent. It is a compound barrier made of customer processes, key suppliers, intellectual property, service networks, and delivery capability.

  Switching costs: extremely high, and self-reinforcing as the installed base grows. Once customers embed the equipment into fabs and process nodes, replacement costs go far beyond the purchase price. This moat deepens as the aftermarket expands. Installed Base Management sales were €8.19 billion in 2025, and €2.5 billion in Q1 2026 alone. The more machines are installed, the more customers rely on service, upgrades, and software, and the stronger the stickiness becomes.

  The moat has translated into profits; it is not merely a paper advantage. Pricing power is verifiable. Gross margin stayed at 50.5%–52.8% in 2021–2025, and the 2025 operating margin was 34.6%, according to the report. Management has also said it will pass most tariff-related costs on to customers, which is evidence of real pricing power. TTM ROIC is about 35.5%, showing excellent capital efficiency. The moat is genuinely monetized, not just narrated.

  Will the moat widen or narrow over three to five years? Split it by dimension: Widening: High-NA EUV generational upgrades, with a single tool at about $400 million according to the report’s Reuters citation, improvements in EUV source power and yield, and more service-like and software-heavy aftermarket revenue all raise value per customer and switching difficulty. Stable: DUV share and core customer relationships, with the report citing Fitch naming the three major customers TSMC, Intel, and Samsung, face no short-term disruptor. Narrowing: geopolitics is compressing the serviceable market boundary. China’s share had already fallen from 36.1% to 29.1% in 2025, and China export restrictions tightened further after Q1 2026. The moat itself has not been breached, but its “applicable territory” is being cut smaller by external forces.

  Honest conclusion: this is a textbook moat and fully deserves five points out of five, with the technical dimension still deepening. But “monotonically widening over the next three to five years” is too optimistic. The real picture is three forces at once: a wider technical moat, a stable customer moat, and a narrower geopolitical boundary. For long-term holders, the key issue is not whether competitors will surpass ASML, which is highly unlikely. It is how small political forces may cut the market that this moat can enclose.

  Not investment advice. Stock markets involve risk; invest cautiously.

  Jun 10, 2026
• QIf the core business is disrupted, does it have the genes for self-reinvention? How does it handle mistakes and bad news?6/10

  A

  Conclusion: ASML has one textbook proof of self-reinvention: it once bet the whole company on EUV when the end was nowhere in sight, and it won. That is a real reinvention gene. But be clear: its reinvention has been a generational leap along the lithography axis, not a move into something else after the core was disrupted. On bad news, the company’s disclosure is relatively candid, but in recent years it has also narrowed disclosure around the metric the market cares about most. Both sides need to be seen together.

  Hard evidence of reinvention genes: the EUV bet was right. The report cites Reuters saying EUV took nearly twenty years and billions of euros of R&D from prototype to commercialization. That means ASML spent nearly two decades continuously investing in a potentially failed disruptive technology under highly uncertain outcomes, and ultimately turned it into today’s position as the only commercial EUV supplier. This is the organizational gene of being willing to sacrifice the present for a distant future, and of having the ability to cash in a huge bet. ASML genuinely has the trait Baillie Gifford values most.

  Is it repeating that gene today: High-NA is a continuation of the same kind of large bet. The company is now allocating resources to High-NA EUV, with a single tool at about $400 million according to the report’s Reuters citation, and is pressing ahead despite customer cost sensitivity and uncertain commercialization timing. R&D intensity is verifiable: 2025 R&D expense was €4.699 billion, according to the report. The 2025 gross margin improvement did not come from cutting R&D, which shows it did not sacrifice long-term technology bets for short-term profit.

  The boundary of its reinvention genes must be stated honestly. ASML’s reinventions all occurred along the lithography axis, from DUV to EUV to High-NA. It has never shown the ability to pivot into a completely different business after its core lithography business is disrupted. The report also admits, in discussing facts that would overturn the thesis, that if customers prove the EUV/High-NA technology path is economically invalid, that would be a trigger for reassessment. In other words, ASML’s fate is deeply tied to the lithography path. If the lithography paradigm itself were displaced by some disruptive alternative, which is not visible today but cannot be ruled out, whether its reinvention capability would be enough remains untested.

  How it handles mistakes and bad news: mainly candid, but with some narrowing. On the positive side, the report notes that the company’s annual and quarterly reports discuss export controls, demand volatility, working capital, and supply constraints fairly explicitly. During the cautious demand period in 2024, margins did not collapse, indicating solid operating discipline. On the negative side, the report says the company decided it would no longer continuously disclose bookings, the metric most watched by the market, because it is too volatile and can cause misinterpretation. From a long-term operating perspective, this may not be bad, but it objectively narrows short-term transparency for outside investors. This is not hiding bad news, but it does reduce observable signals before bad news suddenly hits.

  Honest conclusion: the reinvention gene truly exists and has been validated by one historic all-in bet. ASML is stronger than most companies on this item. But its reinvention is a generational leap within the main axis, not cross-boundary rebirth after core disruption; the latter has never been tested. Its treatment of bad news is generally candid, and margins held up through demand troughs, but the weakening of key metric disclosure is a subtle narrowing that deserves continued attention.

  Not investment advice. Stock markets involve risk; invest cautiously.

  Jun 10, 2026
• QDoes management, especially the founder, have a long-term view and deep alignment with the company? Is it willing to sacrifice current profits for five to ten years out?4/10

  A

  Conclusion: ASML management has a strong long-term view and, behaviorally, is indeed willing to sacrifice current profits for five to ten years out; sustained high R&D is the evidence. But “deep alignment of interests with the company” is clearly weaker. This is a professional-manager company, with no founder-style massive ownership, and executives’ personal shareholdings are small in absolute company terms. So ASML satisfies “long-termism,” but not the kind of “founder heavily invested, personal net worth tied to the company’s fate” alignment that Baillie Gifford most prefers.

  Long-term view and “sacrificing the present for the distant future”: behaviorally verifiable. The hardest evidence is R&D. 2025 R&D expense was €4.699 billion, according to the report, and the 2025 gross margin improvement was achieved while R&D continued to increase, not by cutting R&D for short-term profit. Historically, the evidence is even more extreme: the report cites Reuters saying EUV took nearly twenty years and billions of euros from prototype to commercialization. That is an institutionalized expression of “willingness to keep investing for a distant future,” not a slogan.

  Interest alignment: weak, because this is a professional-manager structure. The report explicitly discloses that as of the end of 2025, all Board of Management members met minimum shareholding requirements. CEO Christophe Fouquet held 7,040 shares, with a value equivalent to about 5.77 times his base salary; CFO Roger Dassen was at 7.81 times. At the current share price, about $1,777 for the U.S. listing on 2026-06-09, the CEO’s holding is in the tens of millions of dollars, which is meaningful relative to his compensation, but almost negligible versus the company’s roughly $671B market value. The report’s own wording is restrained: compared with many U.S.-style founder companies, this is not a huge personal holding, but at least it is not a completely asset-light employee mentality. That is an honest neutral assessment. Alignment comes from the system, minimum holding requirements and compensation linkage, not from a founder’s personal fortune.

  Other positive signals on management quality. CEO Christophe Fouquet took over in 2024, and the report cites Reuters saying he is a company veteran who long led the EUV business, so professional continuity is strong. Capital allocation is broadly rational: in 2025 ASML returned about €8.5 billion to shareholders through dividends and buybacks, and in early 2026 announced a buyback plan of up to €12.0 billion, running through the end of 2028. The report notes that weighted average shares fell from about 410 million to about 389 million in 2021–2025, showing that buybacks truly reduced share count rather than merely offsetting incentive dilution.

  One issue to watch. The report discloses that in 2025 the company invested about €1.30 billion in Mistral AI. The amount is not large relative to ASML’s scale, but under traditional capital-allocation discipline it is a strategic investment that needs continued observation, not a high-certainty cash return. The report classifies it as not damaging the capital-allocation assessment, but as a reminder that management does not handle every euro through the simplest dividend and buyback logic. That calibration is appropriate.

  Honest conclusion: ASML scores solidly on long-term view and willingness to sacrifice current profit for the future. It is a genuine long-termist company. But founder and executive deep ownership alignment is clearly weak; the anchor is institutional, not personal net worth. This item should not receive full marks just because the company is excellent. For long-term investors, this means you are backing a disciplined professional-manager system, not a founder who has put nearly all of his wealth on the table.

  Not investment advice. Stock markets involve risk; invest cautiously.

  Jun 10, 2026
• QIf it disappeared tomorrow, how much would customers miss it? Is its growth model sustainable and not dependent on harming society or regulators?7/10

  A

  Conclusion: if ASML disappeared tomorrow, customers would miss it to the point that the entire advanced semiconductor industry would stall. Its indispensability is in the highest tier in the market. The growth model itself is highly sustainable and does not rely on harming society, since it sells compliant industrial equipment, not addictive products or products with externalities. But its growth territory depends heavily on regulatory and geopolitical permission. That is the real weakness on the “regulatory sustainability” side of this Baillie Gifford question’s double test.

  Indispensability: close to “no ASML, no advanced chips.” In EUV, the step that determines the limit of advanced logic and memory processes, ASML is currently the only commercial supplier. Supply-chain dependence is equally striking: the report cites ZEISS SMT saying that about 80% of the world’s chips use optical systems it provides together with ASML. The report cites Fitch identifying customer concentration as a credit constraint and naming the three major customers TSMC, Intel, and Samsung. This means that if ASML halted, the advanced-node roadmaps of TSMC, Intel, and Samsung would break directly, with knock-on effects across almost all AI chips, premium smartphones, and data centers. This degree of “being missed” sits at the ceiling among companies.

  Indispensability is also self-reinforcing. Once customers embed the equipment into process nodes, switching costs are extremely high, and the aftermarket deepens reliance. Installed Base Management sales were €8.19 billion in 2025 and €2.5 billion in Q1 2026 alone. Customers rely not only on its machines, but also on its service, upgrades, and software to maintain fab yield and throughput.

  Whether growth “does not harm society”: this side is clean. ASML sells compliant industrial capital equipment. Demand comes from customers’ real production and capacity expansion, with no addictive, misleading, or socially shifted negative externalities. Its high margin comes from technical barriers and pricing power, with a 2025 gross margin of 52.8%, not from exploiting consumers or regulatory arbitrage. In terms of whether its growth model is healthy, ASML has no moral or social sustainability flaw.

  But “regulatory sustainability” is a real weakness. In this Baillie question’s double test, the second layer is whether growth does not depend on damaging regulators or being hit back by regulation. ASML’s growth territory is heavily shaped by export controls: China’s customer share had fallen from 36.1% to 29.1% in 2025, and China export restrictions tightened further after Q1 2026. The report also notes that the company’s 2026 guidance incorporates uncertainty around export-control discussions. This is not “ASML harming regulation.” It is “ASML’s growth being continuously sliced by regulation and geopolitics.” Growth sustainability depends not on ASML alone, but on policy bargaining among the Netherlands, the United States, and China.

  Honest conclusion: indispensability is near perfect, and social sustainability is clean. ASML is extremely strong on both. But the regulatory-sustainability side is not under its control. Its growth territory is being compressed unilaterally by export controls, a structural, long-term constraint that could worsen. It is wrong to think “indispensable, therefore growth is worry-free.” The more indispensable ASML is, and the closer it sits to the center of great-power technology competition, the higher the risk of regulatory pushback. Both sides of this tension must be held at once.

  Not investment advice. Stock markets involve risk; invest cautiously.

  Jun 10, 2026
• QWhat are the unit economics of this business, including gross margin and incremental returns? Do they improve or deteriorate with scale? Where does the money it earns go?7/10

  A

  Conclusion: ASML’s unit economics are top tier: long-term gross margin above 50%, TTM ROIC around 35%, and strong free-cash-flow conversion. As scale grows, unit economics generally improve, because a more service-like aftermarket lifts margin and a larger installed base spreads R&D. But this is not a “zero capital employed” asset-light model. Inventory and working capital expand materially with capacity growth. The money earned mainly goes to R&D, dividends and buybacks, and a conservative balance sheet. Capital allocation is rational, though one strategic investment needs monitoring.

  Gross margin and profitability: structurally high and still rising. Gross margin stayed at 50.5%–52.8% in 2021–2025, reached 52.8% in 2025, and reached 53.0% in Q1 2026, showing a mild upward trend. More importantly, this gross-margin improvement did not come from cutting R&D; 2025 R&D still reached €4.699 billion, according to the report. The company’s 2030 gross-margin opportunity range is 56%–60%, implying structural room for unit economics to improve further.

  Incremental returns: excellent, with TTM ROIC around 35%. The latest TTM ROIC is about 35.5%, while the Dec 2025 basis is about 29%. Capital efficiency is first tier within semiconductor equipment. Combined with a net-cash balance sheet, this is the rare mix of high returns and low financial risk.

  What improves with scale: aftermarket leverage plus higher service quality. As the installed base expands, Installed Base Management, a sticky and relatively stable revenue stream, keeps compounding. IBM sales were €8.19 billion in 2025, up 26.2% year over year, faster than system sales at 12.4%. A rising aftermarket mix improves both gross-margin stability and predictability. This is the positive flywheel of “the larger the scale, the better the business quality.”

  What deteriorates or needs watching with scale: this is not zero capital employed, and cash flow is bumpy. The report shows inventory rising from €5.18 billion in 2021 to €11.43 billion in 2025. Capacity expansion consumes real working capital. Cash flow is very uneven: free cash flow fell to €3.25 billion in 2023, according to the report; Q1 2026 free cash flow was negative, at -€2.608 billion on the report’s basis, with quarterly effects from prepayments, shipments, and working capital. So “good unit economics” must be discussed together with “bumpy quarterly cash flow that cannot be mechanically extrapolated.” The report also flags that in H1 2025 the company sold receivables through factoring, about €1.47 billion on the report’s basis, and included this in operating cash flow. That is a reminder that reported CFO should not be equated with freely distributable cash without adjustment.

  Where the money goes: R&D first, shareholder returns, and net cash. In 2025, ASML returned about €8.5 billion to shareholders through dividends and buybacks. In early 2026 it announced buybacks of up to €12.0 billion through the end of 2028. The report notes weighted average shares fell from about 410 million to about 389 million in 2021–2025, a real share-count reduction. The balance sheet remains net cash, about €9.6 billion on the report’s rough calculation. The one item to watch is the 2025 strategic investment of about €1.30 billion in Mistral AI, according to the report, whose certainty is lower than dividends and buybacks.

  Honest conclusion: unit economics are the least disputable strength of this company: high gross margin, high ROIC, strong cash conversion, and further improvement with scale and aftermarket growth. It still needs to be said honestly that ASML is not asset-light, quarterly cash flow is bumpy, and factoring and working-capital effects add accounting noise. Capital allocation is rational and restrained, with R&D first, real share-count reduction, and net cash; only one strategic investment needs continued observation.

  Not investment advice. Stock markets involve risk; invest cautiously.

  Jun 10, 2026
• QWhat conditions must hold for it to rise fivefold over ten years? Are those conditions realistic? What expectations are embedded in today’s share price?3/10

  A

  Conclusion: starting from the current share price, about $1,777 for the U.S. listing and about €1,508 in Amsterdam on 2026-06-09, with a market value of about $671B / €584B and a trailing P/E of about 58 times, a fivefold rise over ten years would require ASML’s market value to reach about €2.9 trillion. Four conditions must hold at the same time: a large profit ramp, no meaningful valuation multiple compression for ten years, no worsening of geopolitical risk, and successful High-NA execution. At today’s price, which is already about 20% above the report’s anchor of €1,249, that combined set of conditions looks unlikely. Today’s share price embeds a neutral-to-optimistic scenario already priced in.

  The conditions required for a fivefold rise over ten years, all indispensable: First, earnings: net income would need to grow roughly 4–5 times over ten years, assuming the exit valuation multiple is unchanged. 2025 net income was €9.61 billion. A fivefold market value, under an unchanged-multiple assumption, also requires profits to approach fivefold, implying a ten-year net income CAGR of about 17%. But the company’s own 2030 revenue opportunity upper end is only €60.0 billion, versus €32.67 billion in 2025, or +84% over five years. To lift profit fivefold over ten years, ASML would need another strong second half of growth after 2030, which is already beyond the currently visible guidance framework. Second, valuation: P/E cannot shrink meaningfully. Today’s trailing P/E is about 58 times. If the market gives ASML a typical high-quality mature industrial leader multiple of 25–30 times ten years from now, multiple normalization alone would consume more than half the upside. In that case, profits would need to grow about 10 times to deliver a fivefold market value, which is almost impossible. So “fivefold” depends heavily on the market still being willing to award ASML a multiple close to today’s very high level ten years from now. Third, geopolitics: export controls must not worsen further. China’s share had already fallen to 29.1% in 2025, and restrictions tightened again after Q1 2026. A fivefold scenario needs this boundary to at least stabilize and stop being cut further. Fourth, technology: High-NA EUV must scale smoothly and customers must accept the economics. The report notes high cost and uncertain timing, with a single tool at about $400 million.

  Are these conditions realistic: each is possible on its own, but the combined probability drops sharply. Profit growth has AI capex support, and ASML leads the technology path, so those two conditions are not absurd individually. But “a very high ~58 times valuation does not compress for ten years” and “geopolitics does not worsen for ten years” are exogenous conditions that run against historical experience and current trends. All four must occur at the same time for a fivefold outcome. That is a low-probability joint event, not the base expectation. The report’s own expected annualized return range also confirms this: conservative about 2%–4%, neutral about 6%–8%, optimistic about 10%–12%. Even the optimistic scenario compounds to only about 1.6–3.1 times over ten years, far short of “fivefold.”

  What today’s price embeds: a neutral-to-optimistic scenario is already priced in, with little obvious margin of safety. The report’s intrinsic value estimate gives a neutral scenario of about €850–€1,100 per share and an optimistic scenario of about €1,400–€1,600 per share. The current price of about €1,508 already sits inside the optimistic scenario range and is about 20% higher than the report’s €1,249 price at drafting. In other words, the market has not only priced in neutral growth; it has already capitalized a meaningful part of the optimistic case, including High-NA scaling, long-term resonance with AI capex, and sustained high margins. The report’s sober comparison still holds and is now more extreme: current FCF yield is only about 2.3%, noting that the report calculated this at €1,249 and today’s higher price makes FCF yield even lower, while the U.S. 10-year Treasury yield is about 4.61%. The purchase return depends entirely on many years of high growth being delivered, not on current cash yield.

  Honest conclusion: a fivefold rise over ten years is not impossible, but it requires a large profit ramp, a very high valuation multiple not compressing for ten years, no geopolitical worsening, and High-NA execution all happening together. That is a low-probability joint scenario. Today’s price already brings forward neutral-to-optimistic expectations, with little obvious margin of safety. This is the core reason the report gives a “Watch” rating rather than “Buy.” The key question is not whether the company will become better, but whether at this price new investors have almost no room to be wrong.

  Not investment advice. Stock markets involve risk; invest cautiously.

  Jun 10, 2026
• QWhy has the market not realized all this yet? Is it too hard to understand, too easy to dismiss, or too far out? What will become the “narrative inflection point”?3/10

  A

  Conclusion: this Baillie Gifford question assumes “the market has not yet realized this great company,” but for ASML the honest answer must be reversed. The market has already fully, and perhaps excessively, recognized its greatness. ASML is not an overlooked stock buried because investors do not understand it, dismiss it, or fail to look far enough. It is a star stock widely understood, broadly agreed upon, and generously priced. The real perception gap is not “the market underestimates ASML,” but possibly “the market overestimates the odds at the current price.” For ASML today, the so-called “narrative inflection point” is more likely downward, disproving the optimistic story, than upward, being rediscovered.

  The market has not failed to notice; it has noticed thoroughly. Three pieces of evidence: First, valuation is already extremely high. The current trailing P/E is about 58 times, well above about 50.5 times when the report was drafted. The share price has risen from the report’s anchor of €1,249 to about €1,508. This is not a discount from being dismissed. It is a premium from being highly admired. Second, market sentiment and consensus are highly aligned. Total shareholder return over the past year is about +128%, with the stock recently reaching an all-time high. Sell-side consensus is very optimistic, with about 38 analysts recommending Buy and only 2 recommending Sell, for an overall “Strong Buy” rating. When a stock is expensive, rising, and almost universally bullish, the premise that “the market has not realized it” does not hold. Third, the moat and logic are already market common sense. ASML’s status as the only EUV supplier, its link to AI capex, and its service-like aftermarket, with 2025 IBM at €8.19 billion, are not hidden perception gaps. They are consensus narratives repeated across sell-side reports.

  Where the perception gap actually lies: in the reasonableness of the expectations embedded in the price, not in company quality. If anything may still be underpriced, it is not “how good ASML is,” which is already priced in, but two negative-leaning issues. One is the continuing geopolitical slicing of the market boundary, with China’s share down to 29.1% in 2025 and tightening again after Q1 2026. The other is the fragility of the implicit assumption that an extremely high valuation will not compress for ten years. The report’s sober comparison still holds: current FCF yield is only about 2.3%, below the roughly 4.61% U.S. 10-year Treasury yield. The market may be looking too near and too optimistically, not failing to look far enough.

  What would the narrative inflection point be? For ASML today, most inflection points are downward. The reverse triggers listed in the report are exactly the potential inflection points: AI capex proves to be only a phase of pulled-forward spending; High-NA adoption is slower than expected, with a single tool at about $400 million and customers sensitive to cost; China revenue keeps declining; or the market takes the valuation down from about 58 times to 30–35 times. Any one of these could decouple the “great company” narrative from the “reasonable price” narrative. At that point, even if ASML remains great and profitable, the share price could go through a long and substantial drawdown. An upward inflection point, meaning rediscovery, barely exists because the company has already been discovered.

  Honest conclusion: ASML should not be forced into the standard LTGG template of “the market does not understand this great company.” The market understands it very well, is highly enthusiastic, and prices it very fully. ASML is not a pearl covered in dust; it is a star under a long-running spotlight. The more relevant inflection question is not “when will the market realize how good it is,” but “when will the market realize that the current price has overdrawn that goodness.” This is also the fundamental reason the report gives “Watch” and stresses that a good company is not necessarily a good entry point.

  Not investment advice. Stock markets involve risk; invest cautiously.

  Jun 10, 2026